ALL |
META-ANALYSIS |
CITATIONS |
|
Benefit-Cost Summary Statistics Per Participant | ||||||
---|---|---|---|---|---|---|
Benefits to: | ||||||
Taxpayers | $402 | Benefits minus costs | $225 | |||
Participants | $190 | Benefit to cost ratio | $1.40 | |||
Others | $309 | Chance the program will produce | ||||
Indirect | ($112) | benefits greater than the costs | 51% | |||
Total benefits | $789 | |||||
Net program cost | ($564) | |||||
Benefits minus cost | $225 | |||||
Meta-Analysis of Program Effects | ||||||||||||
Outcomes measured | Treatment age | Primary or secondary participant | No. of effect sizes | Treatment N | Effect sizes (ES) and standard errors (SE) used in the benefit-cost analysis | Unadjusted effect size (random effects model) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
First time ES is estimated | Second time ES is estimated | |||||||||||
ES | SE | Age | ES | SE | Age | ES | p-value | |||||
Disruptive behavior disorder symptoms Clinical diagnosis of a disruptive behavior disorder (e.g., conduct disorder, oppositional defiant disorder) or symptoms measured on a validated scale. |
4 | Primary | 1 | 63 | -0.068 | 0.268 | 4 | -0.037 | 0.161 | 7 | -0.298 | 0.269 |
Attention-deficit/hyperactivity disorder symptoms Clinical diagnosis of attention-deficit/hyperactivity disorder (ADHD) or symptoms measured on a validated scale. |
4 | Primary | 1 | 63 | -0.176 | 0.268 | 4 | 0.000 | 0.141 | 5 | -0.771 | 0.005 |
Parental stress^ Stress reported by a parent, typically measured on a validated scale such as the Parental Stress Index. |
34 | Secondary | 1 | 63 | -0.153 | 0.268 | 34 | n/a | n/a | n/a | -0.669 | 0.014 |
Major depressive disorder^^ Clinical diagnosis of major depression or symptoms measured on a validated scale. |
34 | Secondary | 1 | 9 | -0.762 | 0.475 | 34 | n/a | n/a | n/a | -0.762 | 0.109 |
Detailed Monetary Benefit Estimates Per Participant | ||||||
Affected outcome: | Resulting benefits:1 | Benefits accrue to: | ||||
---|---|---|---|---|---|---|
Taxpayers | Participants | Others2 | Indirect3 | Total |
||
Disruptive behavior disorder symptoms | Criminal justice system | $10 | $0 | $21 | $5 | $36 |
Labor market earnings associated with high school graduation | $62 | $145 | $79 | $0 | $285 | |
K-12 grade repetition | $2 | $0 | $0 | $1 | $3 | |
K-12 special education | $131 | $0 | $0 | $65 | $196 | |
Health care associated with disruptive behavior disorder | $207 | $58 | $213 | $103 | $582 | |
Costs of higher education | ($9) | ($13) | ($4) | ($4) | ($31) | |
Program cost | Adjustment for deadweight cost of program | $0 | $0 | $0 | ($282) | ($282) |
Totals | $402 | $190 | $309 | ($112) | $789 | |
Detailed Annual Cost Estimates Per Participant | ||||
Annual cost | Year dollars | Summary | ||
---|---|---|---|---|
Program costs | $1,389 | 2015 | Present value of net program costs (in 2023 dollars) | ($564) |
Comparison costs | $868 | 2010 | Cost range (+ or -) | 40% |
Benefits Minus Costs |
Benefits by Perspective |
Taxpayer Benefits by Source of Value |
Benefits Minus Costs Over Time (Cumulative Discounted Dollars) |
The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment. |
Abikoff, H.B., Thompson, M., Laver-Bradbury, C., Long, N., Forehand, R.L., Miller, B.L., . . . Sonuga-Barke, E. (2014). Parent training for preschool ADHD: a randomized controlled trial of specialized and generic programs. Journal of Child Psychology and Psychiatry, 56(6), 618-631.
Wells, K.C, & Egan, J. (1988). Social learning and systems family therapy for childhood oppositional disorder: Comparative treatment outcome. Comprehensive Psychiatry, 29(2), 138-146.